2024-11-24 17:37:23
The China NMPA Approves TYVYT® (sintilimab injection) in Combination with Bevacizumab and Chemotherapy in Patients with EGFR-mutated Non-squamous NSCLC who Progressed after EGFR-TKI Therapy
Corporate/ 2023-07-24
The China NMPA Approves TYVYT® (sintili...

ROCKVILLIE,Md. and SUZHOU,China,May 10,2023-- Innovent Biologics,Inc. ("Innovent") (HKEX: 01801),a world-class biopharmaceutical c...

Empowering Innovation to the Global Market with Acro Certify
Corporate/ 2023-07-24
Empowering Innovation to the Global Mark...

NEWARK,Del.,May 6,2023-- For many companies,entering the global market is a daunting challenge. These obstacles can come in various forms. S...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release